Atrial Fibrillation (AF) is a common cardiac arrhythmia that affects millions of people worldwide. It is characterized by an irregular and rapid heart rate, which can lead to a variety of symptoms, including palpitations, shortness of breath, and fatigue. AF can also increase the risk of stroke and other cardiovascular complications. Treatment options for AF include lifestyle modifications, medications, and catheter ablation. The AF market is a rapidly growing segment of the cardiology industry. It is driven by an aging population, increasing prevalence of AF, and the development of new technologies and treatments. The market is expected to continue to grow in the coming years, driven by the increasing demand for better diagnosis and treatment of AF. Some of the major companies in the AF market include Medtronic, Boston Scientific, Abbott, Biosense Webster, and St. Jude Medical. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
